Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial.

Liver Int · 2020 · PMC7702130 · PMID 33047868

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

FibroScan also showed a trend in improved LSM, especially for patients with F3 or F4 (Figure S1 D).

also in 53,322 other papers

a significant trendno p-value reported

General liver function tests, including alanine aminotransferase, aspartate aminotransferase and gamma‐glutamyl transferase, showed a significant trend of normalization throughout the study period (Figure S1 A‐C).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.